Stress, the immune system and vulnerability to degenerative disorders of the central nervous system in transgenic mice expressing glucocorticoid receptor antisense RNA

Brain Research Reviews

Volumn 37, Issue 1-3, 2001, Pages 259-272

  Marchetti, Bianca ^a,b   C Morale, Maria ^b   Testa, Nuccio ^b   Tirolo, Cataldo ^b   Caniglia, Salvatore ^b   Amor, Sandra ^d   Dijkstra, Christine D ^c   Barden, Nicholas ^e  

^a UNIVERSITY OF SASSARI   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d Department of Neurodegenerative Disorders ICSM ^*  (United Kingdom)

^e UNIVERSITÉ LAVAL   (Canada)

Author keywords

Corticotropin releasing factor; Experimental allergic encephalomyelitis; Gender; Glucocorticoid receptor antisense RNA; Hypothalamic pituitary adrenocortical axis; Multiple sclerosis; Neuroimmunomodulation; Stress

Indexed keywords

AUTACOID; COMPLEMENTARY RNA; CYTOPLASMIC RECEPTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOCORTICOID RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; ASTROCYTOSIS; AUTOIMMUNE DISEASE; CONFERENCE PAPER; DEMYELINATING DISEASE; DOWN REGULATION; ENZYME INHIBITION; GLIA CELL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOMODULATION; INFECTION SENSITIVITY; LYMPHOCYTE PROLIFERATION; MACROPHAGE FUNCTION; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; SEX DIFFERENCE; SIGNAL TRANSDUCTION; STRESS; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; GENETIC PREDISPOSITION TO DISEASE; MACROPHAGES; MICE; MICE, TRANSGENIC; NEURODEGENERATIVE DISEASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, GLUCOCORTICOID; RNA, ANTISENSE; SEX FACTORS; STRESS; T-LYMPHOCYTES;

EID: 0035659977     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(01)00130-8     Document Type: Conference Paper

References (104)

1. Prenatal exposure to high levels of glucocorticoids increase the susceptibility of cerebellar granule cells to oxidative stress-induced cell death
2. Identification of epitopes of myelin oligodendrocytes glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB//H mice
3. Encephalitogenic epitopes of myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2Ag7) mice share an aminoacid motif
4. Immunosuppression by glucocorticoids: Inhibition of NF-κ B activity through induction of Iκ B synthesis
5. Immortalized hypothalamic LHRH neurons induce a functional shift in astroglia responsiveness to growth factors
6. Insulin-like growth factor effects on ADP-rybosylation processes and interactions with glucocorticoids during maturation and differentiation of astroglial cells in primary culture
7. Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense-RNA against the glucocorticoid receptor
8. Prenatal stress and immunocompetence in later life
9. Molecular determinants of glucocorticoids receptor function and tissue sensitivity to glucocorticoids
10. In utero programming of chronic disease
11. Anti-inflammatory actions of steroids: Molecular mechanisms
12. Intravenous methylpredisolone for multiple sclerosis in relapse
13. Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression
14. Regulation of chronic relapsing experimental encephalomyelitis by endogenous and exogenous glucocorticoids
15. Oligodendrocytes as glucocorticoids target cells: Functional analysis of the glycerol phopshate dehydrogenase gene
16. Neonatal exposure to glucocorticoids: Long term endocrine and behavioral effects
17. The role of the hypothalamic-pituitary-adrenal axis in susceptibility to autoimmune/inflammatory diseases
18. The stress response and immune function: Clinical implications
19. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
20. Aminoguanidine an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice
21. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions
22. Feedback action and tonic influence of corticosteroids on brain function: A concept arising from the heterogeneity of brain receptor systems
23. Brain corticosteroid receptor balance in health and disease
24. Inhibition of reactive proliferation of lymphocytes by activated macrophages: The role of nitric oxide
25. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages
26. Neuroendocrine modulation of chronic relapsing experimental autoimmune encephalomyelitis: A critical role for the hypothalamic-pituitary-adrenal axis
27. High-dose methylprednisone therapy on leukocyte and soluble adhesion molecule expression
28. Stress mechanisms and the age-related increase in GFAP transcription in brain astrocytes
29. Transcriptional control of hippocampal glial fibrillary acidic protein and glutamine synthetase in vivo: Opposite responses to to corticosterone
30. Messenger RNA for glia fibrillary acidic protein is decreased in the rat brain following acute and and chronic corticosterone treatment
31. Basic fibroblast growth factor (bFGF) acts on both neurons and glia to mediate the neurotrophic effects of astrocytes on LHRH neurons in culture
32. Basic fibroblast growth factor (bFGF) priming increases the response of LHRH neurons to neurotrophic factors
33. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis
34. Effects of intravenous methylprednisone therapy on leukocyte and soluble adhesion molecule expression in MS
35. Distinct distribution and time-course changes in neuronal nitric oxide synthase and inducible NOS in the paraventricular nucleus of the hypothalamus after lypolysaccharide injection
36. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function
37. Long-term effects of intrauterine growth retardation
38. Nitric oxide: A pathogenetic factor in autoimmunity
39. Acute and subacute effects of endotoxin on hypothalamic gaseous neuromodulators
40. Endotoxin stimulates an endogenous pathway regulating corticotropin-releasing hormone and vasopressin release involved in the generation of nitric oxide and carbon monoxide
41. Nitric oxide stimulates ACTH secretion and the transcription of genes encoding for NGF-B, corticotropin-releasing factor, corticotropin-releasing factor receptor type 1, and vasopressin in the hypothalamus of the intact rat
42. Interaction between corticotropin-releasing factor and nitric oxide in mediating the response of the rat hypothalamus to immune stimuli
43. Systemic endotoxin increases steady-state gene expression of hypothalamic nitric oxide synthase: Comparison with corticotropin releasing factor and vasopressin gene transcripts
44. Developmental correlates of stress system dysfunction
45. Blood-brain barrier: Endogenous modulation by adrenal cortical function
46. Role of nitric oxide in the neuroendocrine responses to cytokines
47. Nitric oxide controls the hypothalamic-pituitary response to cytokines
48. The role of adrenocorticoids as modulators of immune function in health and disease: Neural, endocrine and immune interactions
49. Neurodegeneration and the immune system
50. Multiple sclerosis
51. Stress, glucocorticoids and the susceptibility to develop autoimmune disorders of the central nervous system
52. The hypothalamic-pituitary-gonadal axis and the immune system
53. Gender, neuroendocrine-immune interactions and neuron-glial plasticity: Role of luteinizing hormone releasing hormone (LHRH). Neuroimmunomodulation: Perspective at the new millenium
54. Developmental consequences of hypothalamic-pituitary-adrenocortical system disruption: Impact on thymus gland maturation and the susceptibility to develop neuroimmune diseases
55. Cross-talk signals in the CNS: Role of neurotrophic and hormonal factors, adhesion molecules and intercellular signaling agents in luteinizing hormone-releasing hormone (LHRH) neuron-astroglia interactive network
56. The LHRH-astroglial network of signals as a model to study neuroimmune interactions: Assessment of messenger systems and transduction mechanisms at cellular and molecular levels
57. Unique neuroendocrine-immune interactions during pregnancy
58. Neuroendocrineimmunology (NEI) at the turn of the century: Towards a molecular understanding of basic mechanisms and implications for reproductive physiopathology. Invited Review
59. Transgenic animals with impaired type II glucocorticoid receptor expression: A model to study aging of the neuroendocrine-immune system
60. 2-adrenergic receptor
61. 2-adrenergic receptor distribution as revealed by in vitro autoradiography
62. Genetic variation in the stress response: Susceptibility to experimental and implications for human inflammatory disease
63. Early environmental regulation of forebrain glucocorticoid receptor gene expression: Implications for the adrenocortical response to stress
64. High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effects
65. A double-blind controlled trial of high dose methylprednisone in patients with multiple sclerosis: 1. Clinical effects
66. Molecular basis of 'suppressor' macrophages. Arginine metabolism via the the nitric oxide synthetase pathway
67. Disruption of hypothalamic-pituitary adrenocortical system in transgenic animals expressing type II glucocorticoid receptor antisense ribonucleic acid permanently impairs T cell function: Effects on T-cell trafficking and T cell responsiveness during postnatal development
68. Blockade of central and peripheral luteinizing hormone-releasing hormone (LHRH) receptors in neonatal rats with a potent LHRH-antagonist inhibits the morphofunctional development of the thymus and maturation of cell-mediated and humoral immune responses
69. 2-adrenergic receptor messenger RNA concentration in the male rat thymus
70. Role of Th1 and Th2 cells in autoimmune demyelinating disease
71. Gaseous neuromodulators in the control of neuroendocrine stress axis
72. The role of endogenous carbon monooxide in the control of neuroendocrine stress axis
73. Glial responses to steroids as markers of brain aging
74. Aminoguanidine a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phases
75. Nitric oxide induces apoptosis in mouse splenic T-lymphocytes
76. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis
77. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination
78. Circadian melatonin and young-to-old pineal grafting postpone aging and maintain juvenile conditions of reproductive functions in mice and rats
79. Interdependence between neuroendocrine programming and the generation of immune recognition in ontogeny
80. Interdependece of the thymus in programming neuroendocrine functions
81. Modulation of glucocorticoid receptor gene expression in the thymus by the sex steroid hormone milieu and correlation with sexual dimorphism of immune response
82. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene
83. Biology of disease, analysis of autoimmune demyelination: Its impact upon multiple sclerosis
84. Two receptor systems for corticosterone in the rat brain: Microdistribution and differential occupation
85. Aggravation of experimental allergic encephalomyelitis by administration of nitric oxide synthase inhibitors
86. Kinetics of production of reactive nitrogen intermediates during experimental allergic encephalomyelitis
87. Partial blockade of T-cell differentiation and marked alteration of the thymic microenvironment in transgenic mice with a dysfunctional glucocorticoid receptor function
88. Role of transcriptional activation of I κ B α in mediation of immunosuppression by glucocorticoids
89. Neonatal endotoxin exposure alters the development of the hypothalamic-pituitary adrenal axis: Early illness and later responsivity to stress
90. Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation
91. Apoptosis of T cell and macrophages in the central nervous system of intact and adrenalectomized Lewis rats during experimental allergic encephalomyelitis
92. Dexamethasone non-suppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor
93. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats
94. A defect in the central component of the immune system-hypothalamic-pituitary adrenal axis feedback loop is associated with susceptibility to experimental arthritis and other inflammatory diseases
95. Involvement of CD45 in dexamethasone and heat-shock induced apoptosis of rat thymocytes
96. Dexamethasone promotes phagocytosis and bacterial killing by human monocytes macrophages in vitro
97. Discontinuation of treatment with IFN-β leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-β and excessive expansion of autoreactive T cells as disease promoting mechanisms
98. Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases
99. Glucocorticoids and immune function: Physiological relevance and pathogenic potential of hormonal dysfunction
100. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: A review
101. IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: A possible role for nitric oxide